CREEX | VGSLX | CREEX / VGSLX | |
Total Expense Ratio | 1.00 | 0.13 | 769% |
Annual Report Gross Expense Ratio | 1.00 | 0.13 | 769% |
Fund Existence | 31 years | 24 years | - |
Gain YTD | -2.234 | 3.074 | -73% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 3000 | 67% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 156M | 63.6B | 0% |
Annual Yield % from dividends | 2.48 | 3.89 | 64% |
Returns for 1 year | 2.15 | 12.20 | 18% |
Returns for 3 years | -16.73 | 10.14 | -165% |
Returns for 5 years | -10.32 | 36.07 | -29% |
Returns for 10 years | -20.90 | 65.87 | -32% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
INUTX | 39.95 | 0.19 | +0.48% |
Columbia Dividend Opportunity A | |||
WLIVX | 18.20 | 0.08 | +0.44% |
WCM Focused International Equity Inv | |||
TASHX | 15.24 | 0.06 | +0.40% |
Transamerica Multi-Asset Income A | |||
IJPMX | 15.64 | 0.06 | +0.39% |
VY® JPMorgan Mid Cap Value S2 | |||
THISX | 77.59 | 0.27 | +0.35% |
T. Rowe Price Health Sciences I |